Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Vaccine. 2013 Aug 12;31(42):4795–4801. doi: 10.1016/j.vaccine.2013.07.085

Fig. 5.

Fig. 5

There was no significant difference in VN titers (A) and total anti-MV ELISA titers (B) at day 32 between MV-lambda and MV-lambda-NAP-immunized 6–8-week-old Ifnarko-CD46Ge mice. Serum antibodies from 10 to 12-week-old mice (10 per group) showed strong reactivity against MV antigens in ELISA 4-weeks (C) or 6 months (D) post-immunization with MV-lambda or MV-lambda-NAP.